The technology in radiology screening for cancer has advanced tremendously in the last few years. Breast MRI is becoming established as a modality in certain high-risk situations, lung cancer screening with spiral CT has found a place with former smokers, and CT colonography has reached new heights in accuracy.
Research shows that MRI of the prostate is much more sensitive and specific than transrectal ultrasound, even if the overall management of this controversial disease is uncertain. Preoperative imaging of rectal cancer to accurately assess depth of penetration, extracolonic extension and lymph node involvement has improved greatly with the use of MRI as well and is crucial to good decisions in initial management of this tricky disease. Finally the use of PET scanning as a predictor of outcome following initial chemotherapy in patients with high-risk non-Hodgkin Lymphoma is becoming standard-of-care.
All of this information on advances being made in cancer imaging is beautifully summarized in a recent issue of CA A Cancer Journal for Clinicians, published by the American Cancer Society. Formerly a throw-away journal, this offering now has state-of-the-art review articles on important subjects… Read the rest of this article at StarkOncology.com!
About Dr. James Stark
Dr. James Stark is the founder of StarkOncology, where he practiced Oncology in Hampton Roads for thirty-four years. He is now a health-care consultant specializing in topics such as breast cancer, colon cancer, lung cancer, chemotherapy complications, and failure to screen. In addition to this new venture he continues to serve as Professor of Medicine at Eastern Virginia Medical School.